# ZNF57

## Overview
ZNF57 is a gene that encodes the zinc finger protein 57, a member of the KRAB-zinc finger protein (KRAB-ZFP) family, which is involved in transcriptional repression. The protein functions primarily through interactions with the KRAB/KAP1 complex, contributing to the spread of heterochromatin and the silencing of gene expression. Although direct binding of KAP1 to ZNF57 has not been observed, the presence of repressive chromatin marks suggests an indirect role in transcriptional regulation. ZNF57 is located on human chromosome 19 and is implicated in various cellular processes, including DNA repair and replication. Clinically, mutations in ZNF57 have been associated with transient neonatal diabetes and have been studied in the context of glioma pathogenesis, highlighting its potential role in both developmental and disease processes (Stöger2008Epigenetics; Groner2010KRAB–Zinc; ErdemEraslan2015Tumorspecific).

## Structure


## Function
ZNF57 is a member of the KRAB-zinc finger protein (KRAB-ZFP) family, which plays a role in transcriptional repression through heterochromatin spreading. This process involves the interaction of KRAB-ZFPs with the corepressor KAP1, which facilitates the spread of repressive chromatin marks such as H3K9me3 and HP1b from the KRAB-binding site to the promoter region of target genes. This spreading results in transcriptional repression by interfering with RNA polymerase II recruitment and transcriptional initiation (Groner2010KRAB–Zinc).

In the context of ZNF57, although direct binding of KAP1 was not observed, elevated levels of silencing marks were detected in its middle region, suggesting that ZNF57 might be indirectly affected by KAP1-mediated heterochromatin spreading. This indicates a potential role for ZNF57 in maintaining transcriptional repression within a cluster of KRAB-ZFP genes on human chromosome 19 (Groner2010KRAB–Zinc). The presence of these repressive marks suggests that ZNF57 may contribute to the regulation of gene expression by modulating chromatin structure, thereby influencing cellular processes such as DNA repair, replication, and transcriptional regulation.

## Clinical Significance
Mutations in the ZNF57 gene have been associated with transient neonatal diabetes (TND), a rare imprinting disorder. TND affects approximately 1 in 500,000 neonates and is characterized by the need for insulin therapy during the first three months of life, followed by remission. Other manifestations of the 6q24 disorder associated with TND include umbilical hernia, macroglossia, and learning difficulties. Mosaic hypomethylation at multiple imprinted loci is a recurrent feature in individuals with TND, suggesting that these epigenetic lesions are more prevalent in nonleukocyte cells. The basis for aberrant methylation-mosaicism might be established during early embryogenesis, a developmental stage when ZNF57 is normally expressed (Stöger2008Epigenetics).

In the context of cancer, ZNF57 has been studied for its potential role in glioma pathogenesis. Although mutations in ZNF57 were identified in oligodendrogliomas, no significant differences in subcellular localization were found between wildtype and mutant constructs, suggesting that these mutations may not significantly affect its function in gliomas (ErdemEraslan2015Tumorspecific). However, the study indicates that low-frequency gene mutations, including those in ZNF57, could contribute to tumor pathogenesis by affecting protein localization and altering cell proliferation and migration (ErdemEraslan2015Tumorspecific).

## Interactions
ZNF57 is involved in transcriptional repression through interactions with the KRAB/KAP1 complex. Although no direct association between KAP1 and ZNF57 has been detected, elevated levels of silencing marks such as H3K9me3 in the middle region of ZNF57 suggest indirect regulation by KAP1. This indicates that ZNF57 may participate in long-range heterochromatin spreading mediated by the KRAB/KAP1 complex, contributing to transcriptional repression (Groner2010KRAB–Zinc).

The KRAB/KAP1 complex, which includes proteins like HP1 and SETDB1, facilitates the spread of heterochromatin marks, leading to transcriptional silencing. In the context of ZNF57, this complex is thought to play a role in maintaining transcriptional repression and protecting against recombination events (Groner2010KRAB–Zinc).

In KAP1 knockdown HeLa cells, ZNF57 shows slight upregulation, indicating that its repression is at least partially dependent on KAP1 levels. This suggests that ZNF57 is part of a regulatory network involving KRAB-ZFP gene clusters, where KAP1-mediated heterochromatin spreading influences gene expression (Groner2010KRAB–Zinc).


## References


[1. (Stöger2008Epigenetics) Reinhard Stöger. Epigenetics and obesity. Pharmacogenomics, 9(12):1851–1860, December 2008. URL: http://dx.doi.org/10.2217/14622416.9.12.1851, doi:10.2217/14622416.9.12.1851. This article has 61 citations and is from a peer-reviewed journal.](https://doi.org/10.2217/14622416.9.12.1851)

[2. (Groner2010KRAB–Zinc) Anna C. Groner, Sylvain Meylan, Angela Ciuffi, Nadine Zangger, Giovanna Ambrosini, Nicolas Dénervaud, Philipp Bucher, and Didier Trono. Krab–zinc finger proteins and kap1 can mediate long-range transcriptional repression through heterochromatin spreading. PLoS Genetics, 6(3):e1000869, March 2010. URL: http://dx.doi.org/10.1371/journal.pgen.1000869, doi:10.1371/journal.pgen.1000869. This article has 286 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1000869)

[3. (ErdemEraslan2015Tumorspecific) Lale Erdem-Eraslan, Daphne Heijsman, Maurice de Wit, Andreas Kremer, Andrea Sacchetti, Peter J. van der Spek, Peter A. E. Sillevis Smitt, and Pim J. French. Tumor-specific mutations in low-frequency genes affect their functional properties. Journal of Neuro-Oncology, 122(3):461–470, February 2015. URL: http://dx.doi.org/10.1007/s11060-015-1741-1, doi:10.1007/s11060-015-1741-1. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11060-015-1741-1)